Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2020-07-01
2021-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Arm Retraction on the Supraclavicular Approach for Subclavian Vein Catheterization
NCT02478749
The Effect of Tapping in the Venous Dilatation for Peripheral IV Access
NCT05265481
The Effect of Pushing Technique With Saline on Success of Peripheral Intravenous Catheter Placement
NCT05685290
The Process of Blood Collection With a Vascular Imaging Device
NCT05678504
Effects of Dıfferent Tournıques and Posıtıons on Paın, Anxıety Levels and Applıcatıon Success in Perıpheral Intravenous Catheter Applıcatıon: a Randomızed Controlled Study
NCT06862921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Background: In phlebotomy practice, many application guidelines or textbooks are used. In these references, it is seen that phlebotomy site is wiped with different motions.
Methods: This study was conducted with 90 patients. The phlebotomy site was wiped with circular motion in the group-I, vertical movement in the group-II, and first vertical and then circular motion in the group-III.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
circular motion
The phlebotomy site was wiped in a circular motion from the center outwards, approximately 5x5 cm wide.
circular motion
The phlebotomy site was wiped in a circular motion from the center outwards, approximately 5x5 cm wide.
vertical motion
The phlebotomy site was wiped vertically from top to bottom with a single maneuver.
vertical motion
The phlebotomy site was wiped vertically from top to bottom with a single maneuver.
first vertical then circular motion
The phlebotomy site was first vertically wiped from top to bottom with a single maneuver, and then it was wiped in a circular motion from the center to the outside. Different swabs were used in both wipes.
circular+vertical motion
The phlebotomy site was first vertically wiped from top to bottom with a single maneuver, and then it was wiped in a circular motion from the center to the outside.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
circular motion
The phlebotomy site was wiped in a circular motion from the center outwards, approximately 5x5 cm wide.
vertical motion
The phlebotomy site was wiped vertically from top to bottom with a single maneuver.
circular+vertical motion
The phlebotomy site was first vertically wiped from top to bottom with a single maneuver, and then it was wiped in a circular motion from the center to the outside.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* without any psychiatric diseases,
* without vision or hearing problems,
* hospitalized in the internal medicine clinic,
* with platelet counts of 200 000 / mm³ and above,
* 8 cc of blood is ordered for lab test and
* individuals who volunteered to participate in the study
Exclusion Criteria
* having vascular disease,
* having an immunopathological problem,
* scarring, psoriasis, active dermatitis in the phlebotomy site,
* having peripheral nerve disease,
* having peripheral neuropathy,
* patients with coagulation disorder,
* individuals who don't volunteered to participate in the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sevda Korkut
Instructor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sevda Korkut
Role: PRINCIPAL_INVESTIGATOR
TC Erciyes University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
817
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.